Paloma Partners’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-4,324	Closed	-$264K	–	1242
2019 Q4	$264K	Buy	+4,324	New	+$264K	﹤0.01%	1542
2018 Q1	–	Sell	-12,360	Closed	-$290K	–	1448
2017 Q4	$290K	Buy	+12,360	New	+$290K	﹤0.01%	987